Posts Tagged ‘bone marrow transplants’

Right Turn: My favourite things (blogs!)

Author: Stacey Johnson, 12/30/16

  Raindrops on roses and whiskers on kittens, Bright copper kettles and warm woolen mittens, Brown paper packages tied up with strings, Blogs are a few of my favourite things. When the dog bites, When the bee stings, When I’m feeling sad, I simply remember my favourite blogs and then I don’t feel so bad….Read more

Insights from CGTW16 – Part 3: Clinical trials, health economics and regulatory affairs

Author: Guest, 12/01/16

Amin Adibi is a biomedical engineer and a research assistant at the University of British Columbia. His areas of interest include cell manufacturing and bioprocess optimization, clinical translation of cellular therapies, health outcomes and cost-effectiveness modelling. Amin has an MSc degree from University of Calgary, where he focused on developing adjuvant MSC-based therapies for brain…Read more

Right Turn: Finding donors for multi-ethnic patients with rare blood diseases

Author: Guest, 10/07/16

Laine Jaremey is the Communications Specialist at CCRM. Laine has over eight years of experience as a strategic communicator with a focus in the health industry. She completed her Bachelor’s Degree in Communication Studies at Wilfrid Laurier University, and a Postgraduate certificate in Public Relations from Humber College. Follow her on Twitter @LaineJaremey Being diagnosed with…Read more

The story of the first bone marrow transplant

Author: Jovana Drinjakovic, 09/15/16

It was a failed transplant that saved his life. In 1958, Radojko Maksic became the first person to receive a bone marrow graft from a stranger, after he was accidentally exposed to a lethal dose of radiation in Belgrade, in what was then Yugoslavia. He still lives in Belgrade, almost 60 years after the procedure….Read more

Update from the Clinic: January

Author: Mark Curtis, 02/22/16

Welcome to your update from the clinic for the month of January. It was a quiet month in the clinic. However, we did see some clearances for various clinical studies, including Fate’s ProTmune in GvHD and Pluristem’s PLX-R18 in hematopoietic recovery following bone marrow transplant. Pluristem (PSTM) continues to increase the breadth of applications for…Read more

Update from the Clinic: December

Author: Mark Curtis, 01/13/15

. Welcome to your Update from the Clinic for the month of December. bluebird bio’s first four patients are transfusion-free after treatment with its gene therapy Lentiglobin. Fate Therapeutics’ hematopoietic stem cell-modulating technology ProHema seems to be on track to produce results in the clinic. bluebird bio (BLUE), which recently priced a common offering to…Read more

Careful with the heart strings: Promise vs. potential

Author: David Kent, 06/26/14

> The cellular therapy plenary at the ISSCR conference on June 19 was an incredibly interesting mix of hope and despair. On one hand, the opening talk by Leigh Turner made us imagine thousands of people in the United States getting duped into stem cell therapies as a result of pre-mature commercialization and ethically contentious…Read more

Unraveling the mysteries of blood: Gene that regulates self-renewal discovered

Author: Holly Wobma, 08/26/13

Are we beginning to understand the complex conversations that control blood stem cell fate? Researchers in Toronto have found how one gene, GATA-3, helps prolong self-renewal properties. > They say working on the trauma unit isn’t for the faint of heart. But I think this also applies to being an immunologist. Because not only do…Read more

Master debaters have bone (marrow) to pick at StemCellTalks Toronto

Author: Stacey Johnson, 03/27/13

I’ve always had an interest in the science of bone marrow transplants, ever since my nephew, Simon, was diagnosed with aplastic anemia at the age of two.  Although it was a traumatic time for his parents and extended family, the story has a happy ending. His four-year-old brother was a bone marrow match and the…Read more